X4 Pharmaceuticals (XFOR) Preferred Dividend Payments (2017 - 2019)
X4 Pharmaceuticals posted quarterly Preferred Dividend Payments of $592000.0 for Q1 2019, down 20.0% year-on-year from $740000.0 in Q1 2018, and down 21.69% on a QoQ basis from $756000.0 in Q4 2018.
X4 Pharmaceuticals (XFOR) has 3 years of Preferred Dividend Payments data on file, last reported at $592000.0 in Q1 2019.
- For the quarter ending Q1 2019, Preferred Dividend Payments fell 20.0% year-over-year to $592000.0; the trailing twelve-month figure through Dec 2019 stood at $592000.0 (down 80.27% YoY), and the FY2019 full-year result was $592000.0, down 80.27% from the prior year.
- Preferred Dividend Payments for Q1 2019 stood at $592000.0, down from $756000.0 in the prior quarter.
- Across five years, Preferred Dividend Payments topped out at $3.0 million in Q4 2017 and bottomed at $7000.0 in Q1 2017.
- The 3-year median for Preferred Dividend Payments is $740000.0 (2018), against an average of $732444.4.
- Peak annual rise in Preferred Dividend Payments reached 10471.43% in 2018, while the deepest fall reached 74.49% in 2018.
- A 3-year view of Preferred Dividend Payments shows it stood at $3.0 million in 2017, then sank by 74.49% to $756000.0 in 2018, then dropped by 21.69% to $592000.0 in 2019.
- The last three Preferred Dividend Payments figures came in at $592000.0 (Q1 2019), $756000.0 (Q4 2018), and $756000.0 (Q3 2018), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | - |
| 10 | X4 Pharmaceuticals | 182.28 Mn | 182.28 Mn | 2.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2019 | 592,000.00 |
| Dec 31, 2018 | 756,000.00 |
| Sep 30, 2018 | 756,000.00 |
| Jun 30, 2018 | 748,000.00 |
| Mar 31, 2018 | 740,000.00 |
| Dec 31, 2017 | 2.96 Mn |
| Sep 30, 2017 | 16,000.00 |
| Jun 30, 2017 | 13,000.00 |
| Mar 31, 2017 | 7,000.00 |